IL18 and neoplasm: In the present study, we evaluated whether gene therapy with both IL-18 and HSV-TK is more effective than gene therapy with IL-18 or HSV-TK alone for the induction of specific anti-tumor immunity to treat distant tumors and suppress primary tumor growth.